Literature DB >> 9410620

[Expression of proliferation markers PCNA and MIB 1 in verrucous squamous epithelial carcinoma of the oral cavity].

D Theegarten1, A Barfuss, N C Gellrich, S Philippou.   

Abstract

Expression of proliferation markers PCNA and MIB 1 was evaluated in 17 verrucous carcinomas and in five cases of normal squamous epithelium of the oral cavity. Immunohistochemistry revealed no significant differences in the proliferative activities. Highest expression was seen in the basal zones. Proliferative activity in more than 26% of cells is no longer compatible with verrucous carcinoma, but favours the diagnosis of squamous cell carcinoma.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9410620     DOI： 10.1007/BF03043532

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN： 1432-9417


  11 in total

1.  Verrucous carcinoma of the oral cavity.

Authors:  L V ACKERMAN
Journal:  Surgery       Date:  1948-04       Impact factor: 3.982

2.  Oral verrucous carcinoma. Treatment with radiotherapy.

Authors:  M K Nair; R Sankaranarayanan; T K Padmanabhan; C S Madhu
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

3.  Radiotherapy and verrucous carcinoma of the oral cavity. A study of 107 cases.

Authors:  M S Vidyasagar; D J Fernandes; D P Kasturi; R Akhileshwaran; K Rao; S Rao; R V Rao; J G Solomon
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

4.  Ackerman's tumour (verrucous carcinoma) of the oral cavity: a clinico-epidemiologic study of 426 cases.

Authors:  R Rajendran; I Varghese; C K Sugathan; T Vijayakumar
Journal:  Aust Dent J       Date:  1988-08       Impact factor: 2.291

5.  Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1.

Authors:  D McCormick; H Chong; C Hobbs; C Datta; P A Hall
Journal:  Histopathology       Date:  1993-04       Impact factor: 5.087

6.  The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.

Authors:  G Fontanini; P Macchiarini; S Pepe; A Ruggiero; M Hardin; D Bigini; S Vignati; R Pingitore; C A Angeletti
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

7.  Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms.

Authors:  M Barbareschi; S Girlando; F A Mauri; G Arrigoni; L Laurino; P Dalla Palma; C Doglioni
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

8.  Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.

Authors:  J R Goldblum; R Shannon; E P Kaldjian; M Thiny; R Davenport; N Thompson; R V Lloyd
Journal:  Mod Pathol       Date:  1993-11       Impact factor: 7.842

Review 9.  Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.

Authors:  C C Yu; M I Filipe
Journal:  Histochem J       Date:  1993-12

10.  [Verrucous carcinoma of the oral mucosa].

Authors:  B Rink
Journal:  Laryngorhinootologie       Date:  1991-10       Impact factor: 1.057
View more
  2 in total

1.  Angiogenesis, Proliferative Activity and DNA Ploidy in Oral Verrucous Carcinoma: A Comparative Study Including Verrucous Hyperplasia and Squamous Cell Carcinoma.

Authors:  Saumyaranjan Mallick; Monika Breta; Siddhartha Datta Gupta; Amit Kumar Dinda; Biddhu K Mohanty; Manoj K Singh
Journal:  Pathol Oncol Res       Date:  2015-07-09       Impact factor: 3.201

Review 2.  The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma.

Authors:  Federico Maria Gioacchini; Matteo Alicandri-Ciufelli; Giuseppe Magliulo; Corrado Rubini; Livio Presutti; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-03       Impact factor: 2.503
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.